1000 



SUBJECT INDEX 



NADPH: H2O2 oxidoreductase, hydroqui- 



nones, 454-455, 467-468 

 NADPH: methemoglobin oxidoreductase, 



arsenite, 635 



iodoacetate, 59 

 NADPH:NAD oxidoreductase, see NAD: 



NADP transhydrogenase 

 NADPH:nitrate oxidoreductase, iodoace- 

 tate, 154 

 NAD(P)H:nitrate oxidoreductase, 



menadione, 455, 475 



SH reagent comparison, 809 

 NADPH:nitrite oxidoreductase, arsenite, 



635 

 NADPH oxidase, iodoacetate, 59 

 NADPH : trichloroindophenol oxidore- 

 ductase, iodoacetate, 59 

 Naphthazarin, 



Euglena growth, 574 



glucose metabolism, 486 



hydrogen bonding in, 426 



methemoglobin formation, 516 



planaria, 576 



structure of, 425 



yeast growth, 568, 570 

 1 ,4-Naphthohydroquinone, 



fibroblast mitosis, 528 



ionization constant of, 427 

 1,4-Naphthohydroquinone-diphosphate, 



fibroblast mitosis, 527-530 

 a-Naphthol, mitosis, 524 

 ^-Naphthol, mitosis, 524 

 1 ,2-Naphthoquinone, 



bacterial growth, 547, 552 



bioluminescence, 496-497 



carcinogenicity of, 539 



cress seedling growth, 537 



enzyme inhibitions, 447-449, 451-453, 



455-458, 466 



fermentation in yeast, 482 



fungal growth, 562, 566, 568 



glycolysis (aerobic), 483 



hemolysis, 517 



I" incorporation into thyroid proteins, 



494 



methemoglobin formation, 489, 516 



NADH oxidation by, 434 



oxidation-reduction potential, 430 



planaria, 576 



reaction with y-globulin, 444-445 



stability of, 433 



virus inactivation, 578-579 

 1 ,4-Naphthoquinone, 



autoxidation of, 433 



bacterial growth, 544-550, 552, 554 



bioluminescence, 489, 496-497 



blood pressure, 514 



carcinogenicity of, 539 



central nervous system, 514 



determination of, 435 



embryogenesis, 525 



enzyme inhibitions, 447-451, 453-462, 



466, 469 \ 



Euglena growth, 574 1 



FADH2 oxidation, 477 



fermentation in yeast, 482 



fungal growth, 561-569 



glucose utilization, 481, 486 



glycogen formation, 481 



glycolysis (aerobic), 483 



heart, 501 



hemolysis, 517 



inflammatory action, 505 



I~ incorporation into thyroid proteins, 



494 



lethal doses, 509 



lipid biosynthesis, 493 



methemoglobin formation, 489, 516 



mitosis, 522-523 



NADH oxidation by, 434 



oxidation-reduction potential, 430 



oxidative phosphorylation, 480 



planaria, 575-576 



protein biosynthesis, 493 



pyruvate accumulation, 491 



pyruvate decarboxylase, 457-458, 572- 



573 



reactions with thiols, 437 



respiration (glucose), 487 



skin hyperplasia, 539 



solubility of, 428 



spore germination, 572-573 



virus inactivation, 578-579 

 Naphthoquinones, see also 1,2-Naphtho- 



quinone, 1,4-Naphthoquinone, and Qui- 



nones, 



